Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors

被引:148
作者
Lu, QR
Park, JK
Noll, E
Chan, JA
Alberta, J
Yuk, D
Alzamora, MG
Louis, DN
Stiles, CD
Rowitch, DH
Black, PM
机构
[1] Dana Farber Canc Inst, Dana Farber Harvard Canc Ctr, Dept Canc Biol, Program Neurooncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dana Farber Harvard Canc Ctr, Dept Pediat Oncol, Program Neurooncol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Neuropathol, Boston, MA 02115 USA
[5] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02129 USA
[6] Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02129 USA
[7] Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA
关键词
D O I
10.1073/pnas.181340798
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The most common primary tumors of the human brain are thought to be of glial cell origin. However, glial cell neoplasms cannot be fully classified by cellular morphology or with conventional markers for astrocytes, oligodendrocytes, or their progenitors. Recent insights into central nervous system tumorigenesis suggest that novel molecular markers might be found among factors that have roles in glial development. Oligodendrocyte lineage genes (Olig1/2)encode basic helix-loop-helix transcription factors. In the rodent central nervous system, they are expressed exclusively in oligodendrocytes and oligodendrocyte progenitors, and Olig1 can promote formation of an chondroitin sulfate proteoglycon-positive glial progenitor. Here we show that human OLIG genes are expressed strongly in oligodendroglioma, contrasting absent or low expression in astrocytoma. Our data provide evidence that neoplastic cells of oligodendroglioma resemble oligodendrocytes or their progenitor cells and may derive from cells of this lineage. They further suggest the diagnostic potential of OLIG markers to augment identification of oligodendroglial tumors.
引用
收藏
页码:10851 / 10856
页数:6
相关论文
共 34 条
[1]  
[Anonymous], 2000, Pathology and Genetics of Tumours of the Nervous System
[2]   Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas [J].
Cairncross, JG ;
Ueki, K ;
Zlatescu, MC ;
Lisle, DK ;
Finkelstein, DM ;
Hammond, RR ;
Silver, JS ;
Stark, PC ;
Macdonald, DR ;
Ino, Y ;
Ramsay, DA ;
Louis, DN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (19) :1473-1479
[3]   SUCCESSFUL CHEMOTHERAPY FOR RECURRENT MALIGNANT OLIGODENDROGLIOMA [J].
CAIRNCROSS, JG ;
MACDONALD, DR .
ANNALS OF NEUROLOGY, 1988, 23 (04) :360-364
[4]  
Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO
[5]  
2-W
[6]  
Dahmane N, 1999, DEVELOPMENT, V126, P3089
[7]   Medical progress: Brain tumors [J].
DeAngelis, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (02) :114-123
[8]   Subventricular zone astrocytes are neural stem cells in the adult mammalian brain [J].
Doetsch, F ;
Caillé, I ;
Lim, DA ;
García-Verdugo, JM ;
Alvarez-Buylla, A .
CELL, 1999, 97 (06) :703-716
[9]   Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: A report of Radiation Therapy Oncology Group 83-02 [J].
Donahue, B ;
Scott, CB ;
Nelson, JS ;
Rotman, M ;
Murray, KJ ;
Nelson, DF ;
Banker, FL ;
Earle, JD ;
Fischbach, JA ;
Asbell, SO ;
Gaspar, LE ;
Markoe, AM ;
Curran, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (05) :911-914
[10]   Oligodendroglioma: An appraisal of recent data pertaining to diagnosis and treatment [J].
Fortin, D ;
Cairncross, GJ ;
Hammond, RR .
NEUROSURGERY, 1999, 45 (06) :1279-1291